| Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States A Sarwar, L Zhou, V Novack, EB Tapper, M Curry, R Malik, M Ahmed Hepatology 67 (2), 690-699, 2018 | 61 | 2018 |
| Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study SJ Tepper, J Fang, P Vo, Y Shen, L Zhou, A Abdrabboh, M Glassberg, ... The journal of headache and pain 22, 1-12, 2021 | 22 | 2021 |
| The relevance of readmissions after common IR procedures: readmission rates and association with early mortality A Sarwar, L Zhou, N Chakrala, OR Brook, JL Weinstein, MP Rosen, ... Journal of Vascular and Interventional Radiology 28 (5), 629-636, 2017 | 21 | 2017 |
| Health care utilization and costs in patients with migraine who have failed previous preventive treatments L Newman, P Vo, L Zhou, C Lopez Lopez, A Cheadle, M Olson, J Fang Neurology: Clinical Practice 11 (3), 206-215, 2021 | 13 | 2021 |
| Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration JM Coney, R Zubricky, SB Sinha, N Sonbolian, L Zhou, TP Hull, SA Lewis, ... International Journal of Retina and Vitreous 9 (1), 8, 2023 | 12 | 2023 |
| Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States SJ Tepper, J Fang, L Zhou, Y Shen, P Vo, A Abdrabboh, MB Glassberg, ... Journal of managed care & specialty pharmacy 27 (9), 1157-1170, 2021 | 12 | 2021 |
| Injection intervals in real-world neovascular age-related macular degeneration (nAMD) switch brolucizumab (BROL) patients with at least 12 months of follow-up R Zubricky, J McCoy, SB Sinha, N Sonbolian, L Zhou, R Donkor, ... Investigative Ophthalmology & Visual Science 63 (7), 1313–F0147-1313–F0147, 2022 | 3 | 2022 |
| Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study SJ Tepper, J Fang, L Zhou, P Vo, A Abdrabboh, M Glassberg, M Ferraris Cephalalgia Reports 4, 25158163211040061, 2021 | 2 | 2021 |
| IMPACT OF ERENUMAB ON ACUTE MEDICATION USAGE AND HEALTHCARE RESOURCE UTILIZATION AMONG MIGRAINE PATIENTS: A US CLAIMS DATABASE STUDY SJ Tepper, J Fang, P Vo, A Abdrabboh, M Ferraris, Y Shen, L Zhou, ... CEPHALALGIA 40 (1_ SUPPL), 97-99, 2020 | 2 | 2020 |
| Economic Burden Increased with Number of Treatment Failures in Migraine Patients-A Retrospective Claims Database Analysis in the United States (1485) L Newman, J Huels, P Vo, L Zhou, CL Lopez, A Cheadle, M Olson, J Fang Neurology 94 (15_supplement), 1485, 2020 | 1 | 2020 |
| Economic burden of migraine patients who failed two or more prophylactic treatments-a retrospective claims database analysis in the USA L Newman, J Huels, P Vo, L Zhou, CL Lopez, A Cheadle, M Olson, J Fang CEPHALALGIA 39, 110-110, 2019 | 1 | 2019 |
| One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents JM Coney, JE McCoy, S Buxy Sinha, N Sonbolian, L Zhou, TP Hull, ... Clinical Ophthalmology, 3601-3611, 2023 | | 2023 |
| Characterization of real-world neovascular age-related macular degeneration (nAMD) switch patients treated with brolucizumab (BROL) alternating with other anti-Vascular … J McCoy, R Zubricky, SB Sinha, N Sonbolian, L Zhou, R Donkor, ... Investigative Ophthalmology & Visual Science 63 (7), 1314–F0148-1314–F0148, 2022 | | 2022 |
| Comparative Effectiveness of Erenumab versus Oral Preventive Medications among Migraine Patients: A US Claims Database Study (1821) S Tepper, J Fang, L Zhou, P Vo, A Abdrabboh, M Glassberg, M Ferraris Neurology 96 (15 Supplement), 2021 | | 2021 |
| EFFECTIVENESS OF ERENUMAB AND ONABOTULINUMTOXINA ON ACUTE MEDICATION USAGE AND HEALTHCARE RESOURCE UTILIZATION AS MIGRAINE PREVENTION IN THE UNITED STATES SJ Tepper, J Fang, P Vo, A Abdrabboh, Y Shen, L Zhou, M Glassberg, ... CEPHALALGIA 40 (1_ SUPPL), 90-91, 2020 | | 2020 |
| Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study NA Hanania, J Fang, L Zhou, B Ortiz, A Kavati, X Jaumont, L Alvares, ... European Respiratory Journal 52 (suppl 62), 2018 | | 2018 |
| Causes and rates of 30-day readmissions after percutaneous biliary drainage C Hostage Jr, A Sarwar, J Weinstein, G Kim, N Chakrala, L Zhou, ... Journal of Vascular and Interventional Radiology 2 (28), S55, 2017 | | 2017 |
